{
    "clinical_study": {
        "@rank": "74062", 
        "acronym": "S-ITEDS", 
        "arm_group": [
            {
                "arm_group_label": "Selenium", 
                "arm_group_type": "Active Comparator", 
                "description": "100 micrograms of sodium selenite will be taken orally twice daily (total 200 micrograms daily) for 6 months."
            }, 
            {
                "arm_group_label": "Sugar pill", 
                "arm_group_type": "Placebo Comparator", 
                "description": "A placebo pill will be taken orally twice daily for 6 months."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether sodium selenite is helpful in the\n      treatment of mild thyroid eye disease in North America."
        }, 
        "brief_title": "Selenium in Mild Thyroid Eye Disease in North America", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Thyroid Associated Ophthalmopathies", 
        "condition_browse": {
            "mesh_term": [
                "Eye Diseases", 
                "Thyroid Diseases", 
                "Graves Ophthalmopathy"
            ]
        }, 
        "detailed_description": {
            "textblock": "Thyroid eye disease (TED) is a disease in which the soft tissues surrounding the eye can\n      become inflamed, scarred, and at times permanently damaged in an autoimmune reaction highly\n      associated with abnormal thyroid hormone levels. Some patients have much more severe TED\n      than others, but overall, most patients reach a point with relatively stable TED after 1 to\n      2 years. A recent European study showed that oral selenium, a trace mineral involved in\n      anti-oxidation and immune regulation, could actually alter the course of mild TED, lessening\n      its signs and symptoms and even improving the quality of life of those who took it. The\n      investigators would like to perform a sister study throughout North America. In this\n      randomized, double-blinded, multi-center trial, some subjects with mild TED would be given\n      100 micrograms of sodium selenite twice a day; others would receive a placebo. Signs,\n      symptoms, and quality of life would be measured at regular intervals throughout the 6 month\n      period of drug administration, and for 6 months thereafter."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 18 or older\n\n          -  Able to provide informed consent\n\n          -  Able to swallow pills\n\n          -  Mild thyroid eye disease requiring no past treatment other than ophthalmic drops or\n             ointment\n\n          -  Euthyroid:  at least 2 months if on medication irregardless of thyroidectomy status;\n             at least 6 months after radioiodine therapy; if euthyroid for the year prior to\n             enrollment, needs normal thyroid-stimulating hormone (TSH) within last 3 months; if\n             uncontrolled for the year prior to enrollment, needs normal TSH and free T4 within\n             last 3 months; if TSH low, needs normal T3 and free T4\n\n        Exclusion Criteria:\n\n          -  Moderate or severe thyroid eye disease (based upon International Thyroid Eye Disease\n             Society VISA form), including: grade 2 chemosis or lid edema; corneal exposure with\n             threat of or resulting in perforation; optic neuropathy; grade 3 restriction of any\n             extraocular muscle\n\n          -  Double vision (diplopia) in primary or reading positions\n\n          -  Duration of thyroid eye disease greater than 12 months (as per patient history)\n\n          -  Drug or alcohol abuse\n\n          -  Concurrent or past use of selenium during period of thyroid eye disease\n\n          -  Severe systemic illness (defined by treating physician)\n\n          -  Pregnant or breastfeeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "151", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 8, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02112643", 
            "org_study_id": "AAAL9502"
        }, 
        "intervention": [
            {
                "arm_group_label": "Selenium", 
                "description": "A 100 microgram pill will be orally administered twice a day for 6 months.", 
                "intervention_name": "Sodium selenite", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Selenium"
            }, 
            {
                "arm_group_label": "Sugar pill", 
                "description": "The placebo pill will be constructed to look exactly like the selenium pill, but will have no active ingredients. This will be orally administered for 6 months.", 
                "intervention_name": "Sugar pill", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Placebo"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Selenium"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Thyroid eye disease", 
            "Thyroid orbitopathy", 
            "Graves' orbitopathy", 
            "Graves' ophthalmopathy"
        ], 
        "lastchanged_date": "May 12, 2014", 
        "link": {
            "description": "This is the International Thyroid Eye Disease Society (ITEDS) website.", 
            "url": "http://thyroideyedisease.org/"
        }, 
        "location": [
            {
                "contact": {
                    "email": "suzanne_freitag@meei.harvard.edu", 
                    "last_name": "Suzanne Freitag, MD", 
                    "phone": "617-842-0633"
                }, 
                "contact_backup": {
                    "email": "daniel_lefebvre@meei.harvard.edu", 
                    "last_name": "Daniel Lefebvre, MD", 
                    "phone": "617-571-5138"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02114"
                    }, 
                    "name": "Massachusetts Eye and Ear Infirmary"
                }, 
                "investigator": [
                    {
                        "last_name": "Michael Yoon, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Suzanne Freitag, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Daniel Lefebvre, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Grace Lee, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "mk48@columbia.edu", 
                    "last_name": "Michael Kazim, MD", 
                    "phone": "212-305-5477"
                }, 
                "contact_backup": {
                    "email": "kd2497@cumc.columbia.edu", 
                    "last_name": "Kelly Davis, BS", 
                    "phone": "212-305-0881"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10032"
                    }, 
                    "name": "Edward S. Harkness Eye Institute, Columbia University Medical Center, New York-Presbyterian Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Michael Kazim, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Golnaz Moazami, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Bryan Winn, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Lora R Dagi Glass, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Carisa Petris, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Payal Patel, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "kcahill@columbus.rr.com", 
                    "last_name": "Kenneth V. Cahill, M.D.", 
                    "phone": "614-221-7464"
                }, 
                "contact_backup": {
                    "email": "fosterj@jillfoster.com", 
                    "last_name": "Jill A. Foster, M.D.", 
                    "phone": "614-221-7464"
                }, 
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43215"
                    }, 
                    "name": "Ohio State University"
                }, 
                "investigator": [
                    {
                        "last_name": "Kenneth V. Cahill, M.D.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Jill A. Foster, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Cameron B. Nabavi, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Craig N. Czyz, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Daniel Straka, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Selenium - ITEDS: A North American Study", 
        "other_outcome": {
            "measure": "Fasting glucose level", 
            "safety_issue": "Yes", 
            "time_frame": "Six months"
        }, 
        "overall_official": {
            "affiliation": "International Thyroid Eye Disease Society", 
            "last_name": "Micahel Kazim, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Using GO-QOL score", 
                "measure": "Difference in Quality of Life score", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "description": "GO-QOL score", 
                "measure": "Difference in Quality of Life score", 
                "safety_issue": "No", 
                "time_frame": "Twelve months"
            }, 
            {
                "measure": "Change in Thyroid Eye Disease", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "measure": "Change in Thyroid Eye Disease", 
                "safety_issue": "No", 
                "time_frame": "Twelve months"
            }
        ], 
        "reference": {
            "PMID": "21591944", 
            "citation": "Marcocci C, Kahaly GJ, Krassas GE, Bartalena L, Prummel M, Stahl M, Altea MA, Nardi M, Pitz S, Boboridis K, Sivelli P, von Arx G, Mourits MP, Baldeschi L, Bencivelli W, Wiersinga W; European Group on Graves' Orbitopathy. Selenium and the course of mild Graves' orbitopathy. N Engl J Med. 2011 May 19;364(20):1920-31. doi: 10.1056/NEJMoa1012985."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02112643"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Columbia University", 
            "investigator_full_name": "Michael Kazim", 
            "investigator_title": "Clinical Professor of Ophthalmology and Surgery", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Difference in Clinical Activity Score", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "measure": "Difference in Clinical Activity Score", 
                "safety_issue": "No", 
                "time_frame": "Twelve months"
            }, 
            {
                "description": "TED-PRO", 
                "measure": "Difference in Quality of Life score", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "description": "TED-PRO", 
                "measure": "Difference in Quality of Life score", 
                "safety_issue": "No", 
                "time_frame": "Twelve months"
            }, 
            {
                "description": "TED-QOL", 
                "measure": "Difference in Quality of Life score", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "description": "TED-QOL", 
                "measure": "Difference in Quality of Life score", 
                "safety_issue": "No", 
                "time_frame": "Twelve months"
            }, 
            {
                "measure": "Difference in development of optic neuropathy", 
                "safety_issue": "No", 
                "time_frame": "Twelve months"
            }, 
            {
                "description": "Improvement", 
                "measure": "Difference in Inflammatory Index", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "description": "Improvement", 
                "measure": "Difference in Inflammatory Index", 
                "safety_issue": "No", 
                "time_frame": "Twelve months"
            }, 
            {
                "description": "Deterioration", 
                "measure": "Difference in Inflammatory Index", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "description": "Deterioration", 
                "measure": "Difference in Inflammatory Index", 
                "safety_issue": "No", 
                "time_frame": "Twelve months"
            }, 
            {
                "description": "Improvement", 
                "measure": "Difference in diplopia score", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "description": "Improvement", 
                "measure": "Difference in diplopia score", 
                "safety_issue": "No", 
                "time_frame": "Twelve months"
            }, 
            {
                "description": "Deterioration", 
                "measure": "Difference in diplopia score", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "description": "Deterioration", 
                "measure": "Difference in diplopia score", 
                "safety_issue": "No", 
                "time_frame": "Twelve months"
            }, 
            {
                "description": "Improvement", 
                "measure": "Difference in degrees of restriction", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "description": "Improvement", 
                "measure": "Difference in degrees of restriction", 
                "safety_issue": "No", 
                "time_frame": "Twelve months"
            }, 
            {
                "description": "Deterioration", 
                "measure": "Difference in degrees of restriction", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "description": "Deterioration", 
                "measure": "Difference in degrees of restriction", 
                "safety_issue": "No", 
                "time_frame": "Twelve months"
            }, 
            {
                "description": "Improvement", 
                "measure": "Difference in exophthalmos scores", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "description": "Improvement", 
                "measure": "Difference in exophthalmos scores", 
                "safety_issue": "No", 
                "time_frame": "Twelve months"
            }, 
            {
                "description": "Deterioration", 
                "measure": "Difference in exophthalmos scores", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "description": "Deterioration", 
                "measure": "Difference in exophthalmos scores", 
                "safety_issue": "No", 
                "time_frame": "Twelve months"
            }, 
            {
                "description": "Improvement", 
                "measure": "Difference in eyelid aperture", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "description": "Improvement", 
                "measure": "Difference in eyelid aperture", 
                "safety_issue": "No", 
                "time_frame": "Twelve months"
            }, 
            {
                "description": "Deterioration", 
                "measure": "Difference in eyelid aperture", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "description": "Deterioration", 
                "measure": "Difference in eyelid aperture", 
                "safety_issue": "No", 
                "time_frame": "Twelve months"
            }
        ], 
        "source": "Columbia University", 
        "sponsors": {
            "collaborator": {
                "agency": "International Thyroid Eye Disease Society", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Columbia University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}